Taysha Gene Therapies, Inc. TSHA
4.33 USD +0.24 (+5.87%)
At closeNov 9, 2026, 4:51 AM EST
4.00 -0.33 -7.62%
Pre-market · Nov 9, 4:51 AM ET
4.14 Day range 4.44
3.46 52-week range 7.30
- YTD
- -21.27%
- 1 year
- +10.46%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 9.77M | 8.33M | 15.45M | 2.50M | 0 | |
| 9.77M | 8.33M | 15.45M | 2.50M | 0 | |
| -110.50M | -91.46M | -72.44M | -162.45M | -173.27M | |
| -109.00M | -89.30M | -111.57M | -166.01M | -174.52M | |
| -0.34 | -0.36 | -0.96 | -3.78 | -4.64 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 322.53M | 141.64M | 146.54M | 90.52M | 151.74M | |
| 343.32M | 160.36M | 172.73M | 126.28M | 213.96M | |
| 96.38M | 88.84M | 97.79M | 125.33M | 118.57M | |
| 68.28M | 61.30M | 59.46M | 58.41M | 37.19M | |
| 246.94M | 71.53M | 74.94M | 949.00K | 95.38M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -93.09M | -81.22M | -73.02M | -88.39M | -117.04M | |
| -604.00K | -363.00K | -7.35M | -24.93M | -21.55M | |
| 274.59M | 76.68M | 136.39M | 52.10M | 39.08M | |
| -738.00K | -374.00K | -3.87M | -20.62M | -15.30M | |
| 180.90M | -4.90M | 56.02M | -61.22M | -99.51M |